PARIS / ACCESSWIRE / March 21, 2023 / SFD 2023 - Diabeloop, a pioneer in Automated Insulin Delivery, will collaborate with leading global healthcare company, Novo Nordisk. The agreement covers ...

Novo Nordisk announced plans to make the durable, connected insulin pens NovoPen 6 and NovoPen Echo Plus commercially available across key markets commencing in early 2019. In parallel, to support the ...

Novo Nordisk has announced that two of its smart connected insulin pens, NovoPen 6 and NovoPen Echo Plus will be available within the NHS. NovoPen 6 and NovoPen Echo Plus are novel insulin pens that ...

Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus. Patients will be able connect the mySugr Logbook to ...

When the original NovoPen came out a couple of decades ago it really broke the mould. The new NovoPen 4 from Novo Nordisk is even better. Generally acknowledged as a bit of a design classic, the ‘pen’ ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

The global market for disposable insulin-delivery devices achieved a valuation of US$ 14,585.6 million in 2022. As we step into 2023, the market is poised to increase further, with an estimated value ...

* HAS SIGNED NEW PARTNERSHIP AGREEMENTS WITH LEADING DIABETES TECHNOLOGY COMPANIES THAT SHARE NOVO NORDISK'S VISION TO IMPROVE THE LIVES OF PEOPLE WITH DIABETES: DEXCOM, GLOOKO AND ROCHE * THE LAUNCH ...

On the occasion of the annual congress of the Société francophone du diabète (SFD), in Montpellier, March 21-24, Diabeloop announces a collaboration with Novo Nordisk, a major global healthcare ...